CrossrefInfokarte
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain
ClinicoEconomics and Outcomes Research · 2024-11 · Volume 16 · 785-797
DOI: 10.2147/ceor.s483459 ↗Abstract
Kein Abstract verfügbar.
EUVIMED